Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Yorkshire Water to pay £40m over sewage failings

(Sharecast News) - Yorkshire Water has been ordered to pay out £40m to address serious failings in its sewage and wastewater systems, the regulator confirmed on Thursday. Ofwat said the utility will pay £36.6m between 2025 and 2030 to fix its most problematic storm overflows, with a further £3.4m paid to the Great Yorkshire Rivers Partnership to help clear artificial barriers and improve water quality and biodiversity.

Following a lengthy investigation, starting in 2021, Ofwat found last August that there had been a number of serious failures concerning waste water and sewage at Yorkshire Water. Almost half its storm overflows were found to be in breach of regulations.

Speaking on Thursday, Lynn Parker, senior director for enforcement, said: "Our investigation has found serious failures in how Yorkshire Water has operated and maintained its sewage works and networks, which has resulted in excessive spills from storm overflows.

"This is a significant breach and is unacceptable.

"We are pleased Yorkshire Water has recognised this failure and is taking steps to put it right for the benefit of customers and the environment."

Parker added that the £40m cost could not be passed onto customers and would instead be paid for by the company and its shareholders. Yorkshire Water, which supplies more than 5m customers, is owned by a consortium of infrastructure funds.

Nicola Shaw, chief executive of Yorkshire Water, said: "We know our storm overflows operate more frequently that we or our customers would like them to.

"We've now completed work at 70 storm overflows and we're about to start our £1.5bn programme to reduce discharges even further.

"We know there's still more for us to do. We apologise for our past mistakes."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.